Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posted Basic Consolidated EPS Of $-1.2019

0

Amicus Therapeutics, Inc. (NASDAQ:FOLD) annual basic consolidated EPS was $-1.2019 for the period ended 2015-12-31. The basic consolidated EPS was $-1.2019 for the quarter ended 2015-12-31.

EPS from continuing operations

Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s basic EPS from continuing operations was $-1.2019 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-1.2019

EPS contribution from parent

From the parent company Amicus Therapeutics, Inc. (NASDAQ:FOLD) posted basic EPS of $-1.2019 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-1.2019.

Basic net EPS

The Basic net EPS of Amicus Therapeutics, Inc. (NASDAQ:FOLD) was $-1.2 for the period ended 2015-12-31. The figure stood at $-1.2 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-1.2019. While the figure for the quarter ended 2015-12-31 stood at $-1.2019.

Basic diluted EPS

The diluted EPS from continuing operation of Amicus Therapeutics, Inc. (NASDAQ:FOLD) stood at $-1.2019 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-1.2019

Net diluted EPS

The Net diluted EPS was $-1.2 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-1.2.

Diluted EPS from parent

Amicus Therapeutics, Inc. (NASDAQ:FOLD) diluted EPS from the parent company for the fiscal 2015-12-31 was $-1.2019. The figure for the quarter ended 2015-12-31 was $-1.2019

The net basic EPS was $-0.93 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-0.93.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 6 times, 1 visits today)